The ruling could have implications for employers and others fighting sudden federal policy changes.

The cases, involving big companies that opted out of a big, $2.7 billion settlement, could affect employers' provider networks.

The offer may show employers how hard drug manufacturers will compete based on price, in at least some situations.

Requiring pharmacy benefit managers to pass through updates cut premium changes by an average of 52%.

Activity in a market like Pittsburgh might be 25 times stronger than in some other places, cash-for-coverage program insiders say.

The lead sponsors want government plans to serve as a model for private-sector employers' plans.

The bipartisan effort would make pre-deductible coverage for insulin and statins federal law.

If we can play at being race care drivers and airplane pilots, why not take a turn as the nervous stewards of dwindling pots of premium dollars?